S05221 Summary:

BILL NOS05221
 
SAME ASSAME AS A00509
 
SPONSORSKOUFIS
 
COSPNSRKAPLAN
 
MLTSPNSR
 
Amd §3306, Pub Health L
 
Adds W-18(4-chloro-N-[1-[2-(4-nitrophenyl)ethyl] 2piperidinylidene]benzenesulfonamide) to the schedule of controlled substances.
Go to top    

S05221 Actions:

BILL NOS05221
 
04/16/2019REFERRED TO HEALTH
06/20/2019COMMITTEE DISCHARGED AND COMMITTED TO RULES
06/20/2019ORDERED TO THIRD READING CAL.1820
06/20/2019PASSED SENATE
06/20/2019DELIVERED TO ASSEMBLY
06/20/2019referred to health
01/08/2020died in assembly
01/08/2020returned to senate
01/08/2020REFERRED TO HEALTH
Go to top

S05221 Committee Votes:

Go to top

S05221 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

S05221 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          5221
 
                               2019-2020 Regular Sessions
 
                    IN SENATE
 
                                     April 16, 2019
                                       ___________
 
        Introduced  by  Sen. SKOUFIS -- read twice and ordered printed, and when
          printed to be committed to the Committee on Health
 
        AN ACT to amend the public health law, in relation to adding W-18 to the
          schedule of controlled substances
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section 1. Subdivision (b) of schedule I of section 3306 of the public
     2  health law is amended by adding a new paragraph 58 to read as follows:
     3    (58) W-18 (4-chloro-N-{1-{2-(4-nitrophenyl)ethyl}2piperidinyli-
     4  dene}benzenesulfonamide).
     5    § 2. This act shall take effect immediately.
 
 
 
 
 
 
 
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD02652-01-9
Go to top